I'm gutted. This is a significant blow for chronic cough patients who still have no US approved therapy and for the field broadly. Detailed results will help us better understand what happened and learnings/implications for current/future drugs in development.
#Breaking: The U.S. FDA approves our treatment for moderate-to-severe acute pain in adults. This is the first new class of pain medicine to be approved in over 20 years. Learn more: https://t.co/IYyQfafiBE
Great hearing @rbellini, former CEO of Bellus Health, share his incredible journey from as a "rest of world" microcap company to a multibillion dollar acquisition by GSK to a packed room at #ATS2024.
RBC Global Healthcare Conference: Catching up with @rbellini one year after he sold BELLUS Health to GSK for $2 billion.
Full video: https://t.co/lUQpWqROZ8
A must read thread by $BLU's CEO Roberto Bellini with slides explaining today's results!
Best outcome I was dreaming off, with 50% reduction from baseline at 4 weeks👏💯 & 34% reduction plb/adjusted
This drug is real Best-in-Class!
We had a great time at the Targeting Mitochondria Congress where our very own Dr. Michela Zago presented preliminary data on: “The Effect of Fluorescent Light Energy on Mitochondrial Dynamics”, to an audience of nearly 200 scientists in the field of #Mitochondria! #innovation
$BLUSD will start trading today at the Nasdaq under $BLUS & https://t.co/R0PBfoNwJo in TSX
$BLUS upsized the offering from $60M to $70M at $7.10 (CA$9.40) 👏
https://t.co/E1M0jc59K3
Come meet Dr. Lise Hébert at the Military Health System Research Symposium conference #MHSRS2019
To set a meeting time, please contact her directly at: [email protected]
“One thing that has really stuck with me throughout my time at Klox has been learning to celebrate the little achievements while working towards the larger end goal.” We thank Laura for her @ConcordiaCoop work and wish continued success in her Bachelor of Science in Biology.
. @BrianSkorney notes $MRK this morning highlighted its P2X3 program in chronic cough. This could (should) raise visibility for tiny $BLU and its possibly better P2X3 chronic cough drug, Skorney says. I agree!
https://t.co/io2cTI9I1f
Celebrating #philanthropic initiatives at the Rosalind and Morris Goodman Cancer Research Center, within the @mcgillu Bellini Life Sciences Complex. Mr. Carlo Bellini elaborated on the importance of #research and #development in this state-of-the-art hub.